This poses new challenges for workers, employers, and industrial hygienists, arising from both potential exposure to hazards within the industry, as well as from employees in safety sensitive occupations who may be impaired while on the job as a result of cannabis use. To address these concerns, AIHA will take the following actions in 2019 – 2020:
- Support government-funded research and related efforts to identify hazards within the cannabis industry and support the dissemination of best practices for mitigating or controlling these hazards.
- Champion employer-employee education outreach programs with state and Federal partners to raise awareness of the hazards that exist in the cannabis industry and how to mitigate or control them.
- Support programs that educate employers and employees on existing standards and regulations related to worker health and safety.
- Support research to further understand and define “impairment”.
- Encourage all employers (including governments in their capacities as employers) to voluntarily prohibit the use of cannabis by workers in “safety sensitive” occupations at least until “impairment” is better understood and defined.
- Promote cannabis laboratory testing policies that require labs which identify, handle, and conduct analytical testing on cannabis samples to possess a certificate of accreditation from an accreditation body that complies with the current versions of ISO/IEC 17025 and ISO/IEC 17011, and is a signatory to the International Laboratory Accreditation Cooperation Mutual Recognition Arrangement (ILAC MRA) for Testing.
Letters to policymakers:
- AIHA Comments on Rhode Island NOPR on Cannabis Industry Health and Safety (2019)
- Coalition Letter on IL Public Law 101-0027 on Cannabis Use and Workplace Safety (Senate)
- Coalition Letter on IL Public Law 101-0027 on Cannabis Use and Workplace Safety (House)
- AIHA-COIHC Letter on CA AB 2799 on Cannabis Industry Health and Safety (2018)
- AIHA Letter on Maine LD 1719 (2018)